Kong et al. [287] identified a novel naphthyridine derivative 3u that activated RIPK3/MLKL-dependent necroptosis at lower concentrations while it induced apoptosis at higher concentrations in A375 human melanoma cells. This evidence concerns the gene MLKL and melanoma.